
Tzu Cancer Therapeutics brings good news: with the acquisition of Fetch B.V., the entire chain for isolating and characterizing Circulating Tumor Cells — which play a key role in cancer metastasis — is now under one roof. Read our full press release: tzu.nl/acquisition-fetch-b-v…

